Document is current
Any future updates will be listed below
-
Authors
Tanaka, Atsushi
Taguchi, Isao
Hisauchi, Itaru
Yoshida, Hisako
Shimabukuro, Michio
Hongo, Hiroshi
Ishikawa, Tetsuya
Kadokami, Toshiaki
Yagi, Shusuke
Sata, Masataka
Node, Koichi
,
Asaka, Machiko
Kamishita, Kohei
Kaneko, Tetsuya
Kaneta, Kohei
Natsuaki, Masahiro
Shiraki, Aya
Sonoda, Shinjo
Tago, Motoko
Yajima, Ayumu
Yokoi, Kensuke
Yoshioka, Goro
Nakamura, Ryo
Nishi, Junichiro
Onizuka, Ken
Ise, Takayuki
Kadota, Muneyuki
Kawabata, Yutaka
Kusunose, Kenya
Matsumoto, Kazuhisa
Matsuura, Tomomi
Okushi, Yuichiro
Seno, Hiromitsu
Soeki, Takeshi
Suto, Kumiko
Takahashi, Tomonori
Tobiume, Takeshi
Wakatsuki, Tetsuzo
Yamada, Hirotsugu
Yamaguchi, Koji
Hotta, Yuki
Iwasaki, Mariko
Kazama, Junichiro
Saito, Yu
Sato, Masahiro
Takiguchi, Yoshinori
Tanabe, Hayato
Watanabe, Kiriko
Yamaguchi, Mizuki
Tomita, Sachiko
Kagiyama, Mikiko
Onodera, Keiko
-
Funding
Funding for this research was provided by:
Mochida Pharmaceutical Company
FUJI YAKUHIN
- License Information
-
More Information
Article History
Received: 18 May 2023
Accepted: 4 July 2023
First Online: 17 July 2023
Declarations
:
: The protocol of the DIANA study was approved by the Fukushima Medical University Certified Review Board (No. F2021002 on June 10, 2021) and was conducted in accordance with the Declaration of Helsinki and the Clinical Trial Act in Japan. All patients were informed of the aim and procedures of the study, and all the patients provided written informed consent prior to study participation.
: Not applicable.
: AT has received honoraria from Boehringer Ingelheim and research funding from GlaxoSmithKline, Takeda, Bristol Myers Squibb, and Novo Nordisk. HY has received lecture fee from Kyowa Kirin and outsourcing fees from Organization for Clinical Medicine Promotion. MS received honoraria from Mochida. SY has received honoraria from Bayer and Mitsubishi Tanabe. MS has received honoraria from Bayer, Mitsubishi Tanabe, Nippon Boehringer Ingelheim, Kowa, Novartis, and Mochida, as well as unrestricted research funding from Mitsubishi Tanabe, Nippon Boehringer Ingelheim, Bayer, and Otsuka. KN has received honoraria from Astellas, Bayer, Boehringer Ingelheim Japan, Daiichi Sankyo, Eli Lilly Japan, Kowa, Mitsubishi Tanabe, Mochida, Novartis, Novo Nordisk, Ono, Otsuka, Takeda, Tsumura, and MSD; research grant from Asahi Kasei, Astellas, Boehringer Ingelheim Japan, Fuji Yakuhin, Mitsubishi Tanabe, Mochida, Novartis, Teijin; scholarship from Bayern, Japan Lifeline, and Teijin. All other authors declare no competing interests.
